Explore life science companies operating throughout Greater London, from biotechnology startups to global pharmaceutical organisations.
Molecular serotyping microarrays and surveillance services for vaccine pathogens
BUGS Bioscience is a not-for-profit biotechnology spin-out of the Bacterial Microarray Group at St George's, University of London. The company develops and provides molecular serotyping microarray platforms and associated genomic surveillance services for vaccine-preventable bacterial pathogens, including…
Purpose-built devices and connectivity for clinical trial data collection
Inventus Group is a technology company providing fully provisioned patient and site devices for clinical trials, including OEM smartphones and tablets configured for electronic clinical outcome assessment and eSource data collection. The company's platform integrates device management, global eSIM connectivity across…
Engineered probiotic bacteria producing peptide therapeutics inside the body
Hijack Bio develops engineered probiotic bacteria designed to produce and release peptide therapeutics inside the body. The synthetic biology approach aims to reduce reliance on conventional external manufacturing and cold-chain distribution while enabling oral delivery of peptide drugs. Potential applications include…
AAV gene therapy company targeting inherited and common retinal diseases
Beacon Therapeutics is a clinical-stage UK biopharma company developing adeno-associated virus (AAV) gene therapies for retinal diseases causing blindness. Its lead programme, laru-zova (AGTC-501), is in Phase II/III clinical trials for X-linked retinitis pigmentosa. The pipeline also includes preclinical programmes…
Droplet screening technology for high-throughput biological research
AssureDrop is an early-stage UK biotech company developing droplet-based screening technology for use in drug discovery, biomarker detection, and 3D cell culture research. Its platform enables the generation and handling of droplets directly within standard multiwell plates, including 1536-well format, without the…
Multispecific immune cell engagers targeting gamma delta T cells
Cytospire Therapeutics is developing multispecific engager antibodies designed to enhance and direct the activity of gamma delta T cells for the treatment of cancer and autoimmune disease. The company emerged from stealth in 2024, backed by Abingworth, 4BIO Capital and LifeArc Ventures. Its platform targets both…
Research antibodies, ELISA kits, proteins and peptides for life scientists
St John's Laboratory is a supplier of research antibodies, ELISA kits, proteins and peptides to academia and industry, with a strong focus on serving the UK academic community. The company's product range supports applications including protein research, antibody validation, immunohistochemistry and western blot. St…
Preclinical to late-phase imaging and eClinical trial services
Perceptive is a contract research organisation providing imaging and eClinical services to pharmaceutical and biotechnology companies across the full drug development lifecycle. Its three divisions cover preclinical and in vivo imaging, clinical trial imaging core lab and independent central review, and randomisation…
Programmable RNA delivery platform targeting non-hepatic tissues
Sixfold Bioscience is a biotechnology company developing a programmable RNA-based delivery platform that exploits the body's natural extracellular RNA transport pathways to direct therapeutic RNA molecules to specific non-hepatic tissues and cell types. The platform uses computationally designed chemical modifications…
AI-driven mass spectrometry biomarker services for diagnostics and drug development
Guilford Street Laboratories Ltd is a contract research organisation providing machine learning-powered mass spectrometry services for biomarker discovery, assay development, and precision medicine. The company specialises in high-sensitivity multi-omic analysis of protein, lipid, and metabolite biomarkers, supporting…
Professional network supporting diversity in commercial life sciences
ACCSN is a professional network supporting Black and ethnic minority professionals in commercial science and the wider life sciences industry. The organisation provides mentoring, career development resources, networking opportunities and educational events to improve access to scientific commercial careers. It works…
Long-acting GnRH antagonist for prostate cancer and urinary retention
Antev is a clinical-stage biopharmaceutical company developing a long-acting gonadotropin-releasing hormone (GnRH) antagonist that suppresses testosterone production. Its lead peptide therapy is being developed for men with advanced prostate cancer, including those at high cardiovascular risk, and for men experiencing…
Biophysical platform revealing molecular behaviour for discovery
Apoha is a deep tech company developing a biophysical measurement platform based on nonlinear acoustic wave propagation at liquid interfaces. The platform generates multi-dimensional data on molecular behaviour including responses to stress, motion, and mixture conditions, from small sample volumes. Apoha positions…
Open-source AI models for biomolecular structure and drug design
Boltz is a software and AI company building biomolecular foundation models for drug discovery. Its models predict the three-dimensional structures of proteins and other biomolecules, estimate how strongly small molecules bind their targets, and generate candidate molecules and proteins. Boltz makes models available…
Bayesian oncology models for treatment-response prediction and research
Concr is a London biotechnology software company using astrophysics-derived Bayesian AI to model individual cancer biology and predict treatment responses. Its FarrSight platform combines genomic, molecular and clinical datasets in digital twins, supporting research into patient stratification and oncology drug…
CRO specialising in human challenge trials
hVIVO is a specialist contract research organisation providing human challenge trial services for infectious and respiratory disease. The company conducts controlled human infection studies across more than 14 validated viral challenge models, supporting the development of vaccines and antivirals for clients including…
Portable PCR platform for decentralised genetic testing anywhere
Hyris is a biotechnology company developing a portable, IoT-integrated PCR platform for decentralised nucleic acid testing outside traditional laboratory settings. Its instrument runs proprietary assay cartridges and connects to a cloud-based software platform providing real-time results via a dedicated app. An open…
Neuroimaging contract research organisation for clinical trial biomarker analysis
IXICO is a London-based imaging contract research organisation providing end-to-end neuroimaging services to biopharmaceutical companies conducting clinical trials in neurological diseases. The company collects, manages, and analyses MRI, PET, and SPECT imaging data from global trial sites, generating AI-driven…
Global CDMO for biologics development and manufacture
Lonza is one of the world's largest contract development and manufacturing organisations, providing services across biologics, cell and gene therapy, and small molecules. Its primary UK site in Slough is a multi-product cGMP facility specialising in mammalian biopharmaceutical development and manufacture. The…
Genetic insights to guide drug discovery and development
Sequoia Genetics is a contract research organisation applying human genetic data to inform drug discovery and clinical development. The company works with pharmaceutical companies, biotechnology firms, investors, and academic institutions to generate and interpret genetic insights that can guide target validation and…